Log in to save to my catalogue

Neoantigen vaccine: an emerging tumor immunotherapy

Neoantigen vaccine: an emerging tumor immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3bb25d56ea0440378e7af782d27f8503

Neoantigen vaccine: an emerging tumor immunotherapy

About this item

Full title

Neoantigen vaccine: an emerging tumor immunotherapy

Publisher

England: BioMed Central Ltd

Journal title

Molecular cancer, 2019-08, Vol.18 (1), p.128-14, Article 128

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Genetic instability of tumor cells often leads to the occurrence of a large number of mutations, and expression of non-synonymous mutations can produce tumor-specific antigens called neoantigens. Neoantigens are highly immunogenic as they are not expressed in normal tissues. They can activate CD4+ and CD8+ T cells to generate immune response and ha...

Alternative Titles

Full title

Neoantigen vaccine: an emerging tumor immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3bb25d56ea0440378e7af782d27f8503

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3bb25d56ea0440378e7af782d27f8503

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-019-1055-6

How to access this item